Latest Announcements

Indoco Remedies Limited has informed the Exchange regarding a press release dated Jun 26, 2026, titled "Indoco Remedies Goa Plant successfully clears Malta Medicines Authority audit". The company's manufacturing facility for solid oral dosage form (Plant I) located at Goa has received EU GMP certification from the Malta Medicines Authority confirming that it complies with the Good Manufacturing Practice requirements as referred in the EC Directive.

GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.

Arihant Superstructures Limited has closed its trading window for insiders due to SEBI regulations, effective from July 1, 2026, until 48 hours after the release of Q2 2026 financial results.

DMCC Speciality Chemicals Limited has responded to a query from the National Stock Exchange regarding a significant increase in trading volume of its shares, stating that the movement is market-driven and not due to any undisclosed or price-sensitive information.

MPS Limited has closed its trading window for insiders due to SEBI regulations, effective from July 1, 2026, until 48 hours after the Q1 2026 financial results are declared.

Ester Industries Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.

D-Link (India) Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015. The Trading Window will remain closed for all Designated Persons and their immediate relatives from July 01, 2026, for the consideration of Financial Results for the quarter ending June 30, 2026.

Tega Industries Limited has closed its trading window for insiders due to SEBI regulations, effective from July 1, 2026, until 48 hours after the declaration of unaudited financial results for the quarter ending June 30, 2026.

GACM Technologies Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.

GACM Technologies Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.

Voltamp Transformers Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, effective from July 01, 2026, till 48 hours after declaration of Unaudited Financial Results for the quarter ending on June 30, 2026.

Indo Count Industries Limited has responded to the Exchange's query regarding significant price movement, stating that there is no impending information or unpublished price sensitive information/event that needs to be disclosed. The company assures adherence to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Kothari Sugars And Chemicals Limited has informed the Exchange regarding the renewal of recognition of its In-House R&D Unit(s) by the Department of Scientific and Industrial Research (DSIR) up to March 31, 2029.

Singer India Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015. The Trading Window for dealing in the securities of the Company by the Designated Persons and their immediate relatives will be closed from Wednesday, July 01, 2026 till 48 hours after the declaration of the Unaudited Financial Results of the Company for the quarter ended June 30, 2026.

Valiant Organics Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.

Sampann Utpadan India Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.

Power Mech Projects Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.

Dr. Reddy's Laboratories Limited has informed the Exchange about a Pre-License Inspection (PLI) at its biologics manufacturing facility in Bachupally, Hyderabad, by the United States Food & Drug Administration (USFDA). The inspection was conducted between June 16 and June 25, 2026, and a Form 483 with seven observations was issued. The company will address the observations within the stipulated timeline.

Tata Motors Passenger Vehicles Limited clarifies recent news item regarding partnership with Stellantis, stating that discussions are ongoing but no definitive agreement has been reached. The company confirms that it is not aware of any new information that could explain the recent movement in trading.

Pearl Global Industries Limited has responded to the National Stock Exchange's (NSE) query regarding significant price movement in the company's shares, stating that the movement is due to market circumstances and not any Price Sensitive Information (PSI) that has not been disclosed to the exchange.